BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 662883)

  • 21. [The place of balanced sodium solutions in the treatment of hemorrhage].
    Vourc'h G; Radiguet de la Bastaie P; Triner L; Debbas E; Habif DV; Nahas GG
    Anesth Analg (Paris); 1970; 27(5):737-57. PubMed ID: 5481448
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vascular filling by means of association of a balanced sodium solute and a modified fluid gelatin].
    Joder F; Laborit G
    Agressologie; 1972; 13(2):135-42. PubMed ID: 5078840
    [No Abstract]   [Full Text] [Related]  

  • 23. Acquired fibrinogen deficiency caused by artificial colloid plasma expanders.
    Fenger-Eriksen C
    Wien Klin Wochenschr; 2010 Dec; 122 Suppl 5():S21-2. PubMed ID: 21598444
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on modified fluid gelatin as a plasma substitute. 1].
    Tosaki Y; Asumi N; Takaori M
    Masui; 1968 Apr; 17(4):323-30. PubMed ID: 5692009
    [No Abstract]   [Full Text] [Related]  

  • 25. [The course of anaphylactic shock in dogs reanimated with ansfusions of homologous blood and blood substitutes].
    Enikeev DA
    Eksp Khir Anesteziol; 1967; 12(4):52-7. PubMed ID: 5617074
    [No Abstract]   [Full Text] [Related]  

  • 26. [Severe anaphylactoid complications after infusion of a modified gelatin fluid in balanced solution. 2 prospective studies].
    Blanloeil Y; Gunst JP; Spreux A; Cozian A; Dixneuf B
    Therapie; 1983; 38(5):539-46. PubMed ID: 6670079
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intraoperative anaphylactic/anaphylactoid reaction to infusion of a modified liquid gelatin].
    Israelian LA; Lubnin AIu
    Anesteziol Reanimatol; 2004; (2):36-40. PubMed ID: 15206275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Concerning: "Anaphylactoid reaction to Physiogel SRK 4%--a contribution to the controversy on plasma substitute agents" by T.A. Cron and H. Gerber (Schweiz. med. Wschr. 1991; 127: 1773-1776)].
    Schmid P; Huwyler T; Wüthrich B
    Schweiz Med Wochenschr; 1992 Oct; 122(41):1544-5. PubMed ID: 1411414
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of basophil activation to diagnose allergy to Gelofusine.
    Shields MO; Mirakhur RK; Crockard AD; Edgar JD
    Anaesthesia; 2006 Jul; 61(7):716-7; author reply 717-8. PubMed ID: 16792624
    [No Abstract]   [Full Text] [Related]  

  • 30. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach.
    Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P
    Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indications for plasma substitutes].
    Tschirren B; Hess FA
    Schweiz Med Wochenschr; 1975 Jun; 105(24):771-4. PubMed ID: 1145160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Behavior of blood volume, duration of plasma expansion and side effects after parenteral administration of a gelatin polymer (m. w. 35,000)].
    Allegro G; Brandolin P
    Arch Patol Clin Med; 1970 Aug; 46(3):259-66. PubMed ID: 5491569
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical experience with 120,000 units of modified fluid gelatin.
    Lundsgaard-Hansen P; Tschirren B
    Dev Biol Stand; 1980; 48():251-6. PubMed ID: 7274558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative trials of fluid gelatins on hemostasis in heart surgery in adults].
    Charlet P; Zerr C; Robert D; Merville C; Renouf P; Khayat MC
    Cah Anesthesiol; 1991; 39(4):233-8. PubMed ID: 1933520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anaphylactoid reaction to Hemoce].
    Sanzol Berruezo MR; Quero López J; Pino Capote JA; Fuentes Guerra J
    Rev Esp Anestesiol Reanim; 1984; 31(4):173. PubMed ID: 6536072
    [No Abstract]   [Full Text] [Related]  

  • 37. [A contribution to the therapy of shock with special reference to liquid gelatins as plasma expanders].
    HASCHER H; HASCHER M
    Anaesthesist; 1960 Jul; 9():236-9. PubMed ID: 13851934
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anaphylactoid reaction to Physiogel SRK 4%--a contribution to the controversy about plasma substitutes].
    Cron TA; Gerber H
    Schweiz Med Wochenschr; 1991 Nov; 121(48):1773-6. PubMed ID: 1688371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reducing of unwanted side effects of modified fluid gelatin by promethazine: controlled clinical trial with orthopaedic patints (author's transl)].
    Schöning B; Koch H
    Anaesthesist; 1981 Jan; 30(1):34-43. PubMed ID: 7469003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gelatin allergy].
    Hassoun S; Sabbah A
    Allerg Immunol (Paris); 1998 Mar; 30(3):80-2. PubMed ID: 9582941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.